Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 | 88141968 | 3 prime UTR variant | G/T | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 88141968 | 3 prime UTR variant | G/T | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 88141968 | 3 prime UTR variant | G/T | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 88141968 | 3 prime UTR variant | G/T | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 88141968 | 3 prime UTR variant | G/T | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.050 | 1.000 | 5 | 2007 | 2018 | ||||||
|
0.724 | 0.160 | 6 | 88150763 | intron variant | T/C | snv | 0.21 |
|
Chemically-Induced Disorders; Mental Disorders | 0.050 | 1.000 | 5 | 2008 | 2016 | |||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Mental Disorders | 0.040 | 1.000 | 4 | 2008 | 2013 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Mental Disorders | 0.040 | 1.000 | 4 | 2008 | 2013 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Mental Disorders | 0.030 | 0.667 | 3 | 2002 | 2013 | ||||||
|
0.925 | 0.120 | 6 | 88154934 | intron variant | A/G | snv | 0.26 |
|
Chemically-Induced Disorders; Mental Disorders | 0.030 | 1.000 | 3 | 2006 | 2009 | |||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Behavior and Behavior Mechanisms | 0.020 | 1.000 | 2 | 2007 | 2015 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2012 | 2014 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2010 | 2011 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2009 | 2016 | ||||||
|
0.807 | 0.200 | 6 | 88141462 | 3 prime UTR variant | T/C | snv | 0.11 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.724 | 0.160 | 6 | 88150763 | intron variant | T/C | snv | 0.21 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 88168233 | upstream gene variant | G/A | snv | 0.53 |
|
Behavior and Behavior Mechanisms | 0.020 | 1.000 | 2 | 2009 | 2014 | |||||||
|
1.000 | 0.040 | 6 | 88168233 | upstream gene variant | G/A | snv | 0.53 |
|
Mental Disorders | 0.020 | 1.000 | 2 | 2009 | 2014 | |||||||
|
0.851 | 0.120 | 6 | 88163211 | intron variant | T/G | snv | 0.32 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2009 | 2013 | |||||||
|
1.000 | 0.040 | 6 | 88149832 | intron variant | C/T | snv | 0.21 |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
|
0.630 | 0.600 | 6 | 88143916 | synonymous variant | C/T | snv | 0.21 | 0.20 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2010 | 2010 |